Equine sarcoids are the most common skin tumor in horses worldwide, accounting for approximately 40% of all equine neoplasms (Knottenbelt, Equine Vet J, 2019). They can appear on any horse at any age, are locally invasive, and have a strong tendency to recur after treatment. Despite decades of research, they remain one of the most clinically challenging conditions in equine medicine — not because they are fatal, but because they are difficult to eliminate permanently and can cause significant welfare and performance issues.
What Are Equine Sarcoids?
Sarcoids are locally aggressive, fibroblastic skin tumors. They do not typically metastasize to internal organs, but they grow, ulcerate, and invade local tissues. The cause is strongly linked to bovine papillomavirus (BPV) types 1 and 2 — though the virus alone does not explain distribution (flies are implicated as mechanical vectors; genetic susceptibility via MHC class II genes plays a role). They cannot spread between horses via normal contact, but wound sites and previous sarcoid locations are at elevated risk of new lesions.
The Six Clinical Types
Sarcoids present in six recognized clinical forms, which can occur on the same horse simultaneously and can transform between types — particularly toward more aggressive forms when disturbed or incompletely treated:
1. Occult (Flat) Sarcoid
Circular or irregular areas of gray, scaly, hairless skin. Often found around the eyes, face, and neck. Frequently mistaken for ringworm or rub marks. The least aggressive type at presentation but capable of transforming into verrucous or nodular types, especially after trauma or inappropriate treatment.
2. Verrucous (Wart-like) Sarcoid
Raised, rough, cauliflower-like surface resembling a wart or thick callus. Common on lower limbs, belly, groin, and axilla. Can extend deeper into the dermis than they appear.
3. Nodular Sarcoid
Firm, well-defined nodules under the skin. Type A has normal overlying skin; Type B has thinned skin adherent to the nodule (common in groin and sheath). Type B has higher risk of aggressive transformation and ulceration.
4. Fibroblastic Sarcoid
Aggressive, fleshy, ulcerated masses. Often resembles proud flesh or fungating tumor. Common on lower limbs after trauma or as a consequence of incomplete treatment. High recurrence rate. Can invade deeper structures over time.
5. Mixed Sarcoid
A lesion showing features of two or more types at the same site — for example, a verrucous periphery with a fibroblastic center. Mixed types indicate active transformation and are generally more aggressive.
6. Malevolent (Infiltrating) Sarcoid
The most aggressive type. A network of sarcoid tissue that infiltrates along lymphatic vessels and fascial planes, often visible as a cord of thickened skin running away from the primary lesion. Most common on the face, medial thigh, and axilla. Locally destructive; requires specialist referral.
Common Locations
- Around the eyes (periocular): dangerous due to proximity to the globe
- Ear base, lips, muzzle
- Axilla and groin: thin skin, friction, difficult treatment access
- Sheath and prepuce: very common; fly attraction complicates management
- Lower limbs: especially at wound sites, fetlock, and pastern
- Belly and chest
Diagnosis
Experienced veterinarians often diagnose sarcoids on clinical appearance alone. One critical rule:
Never biopsy a suspected sarcoid without a treatment plan in place. Biopsy can trigger aggressive transformation — a quiescent occult sarcoid can become fibroblastic or malevolent within weeks of being cut. The exception is when diagnosis is genuinely uncertain and treatment will follow immediately. Discuss this with your vet before any biopsy.
Other tools: PCR testing for BPV DNA in atypical presentations. Key differentials: ringworm (dermatophytosis), habronemiasis (summer sores), proud flesh (exuberant granulation tissue), papillomas, melanoma (especially grey horses), squamous cell carcinoma.
Treatment Options
There is no single universally effective treatment. Recurrence rates vary widely between treatments and individual horses. Location, size, type, and number of lesions determine which approach is appropriate.
Do not attempt to treat sarcoids with home remedies (toothpaste, bloodroot paste, caustic household chemicals). These lack evidence, often cause local tissue damage without eliminating tumor cells, and can trigger aggressive transformation.
Cisplatin (Intralesional Chemotherapy)
Cisplatin oil-in-water emulsion or beads injected directly into the tumor at 2-week intervals. Best for accessible, clearly defined lesions under approximately 4 cm. Reported success rates 65–90% for periocular sarcoids (Theon et al., Equine Vet J, 1999). Requires handling of a cytotoxic agent — veterinary administration only. Not suitable for large, diffuse, or malevolent lesions.
Liverpool White Cream (AW4-LUDES)
A topical heavy-metal combination (including arsenic trioxide), available through veterinary channels. Applied at 5-day intervals over a prescribed cycle. Causes controlled necrosis of treated tissue. Effective for flat, verrucous, and some nodular sarcoids. Regulatory availability varies by country. Reported success rates approximately 50–75%. Requires veterinary oversight — damage to surrounding tissue is possible with imprecise application.
Cryotherapy (Liquid Nitrogen)
Liquid nitrogen spray or probes freeze the tumor; multiple freeze-thaw cycles per treatment, typically 2–3 sessions needed. Well-suited for small, flat periocular and some verrucous lesions. Not effective for deep or large tumors. Treated tissue sloughs slowly. Success rates variable (40–80%); recurrence common if deep margin is not reached.
Surgical Excision
Wide excision has recurrence rates of 50–60% for most sarcoid types — sarcoid tissue infiltrates beyond the visible margin, and the surgical wound stimulates recurrence. Most appropriate when combined with another modality (radiation, chemotherapy) or for pedunculated fibroblastic sarcoids with accessible bases. Avoid excision alone for most types.
Radiation (Brachytherapy)
Radioactive implants (iridium-192 or gold-198) placed into tumor tissue. Most commonly used for periocular sarcoids where surgical margins are limited. Reported cure rates of 75–90% in periocular cases (Knottenbelt et al.). Requires specialist facilities and radiation safety protocols. Not widely available; significant cost.
Immunotherapy (BCG Vaccine)
BCG (Bacillus Calmette-Guerin) injected intralesionally stimulates immune response against the tumor. Best results for periocular sarcoids (66% complete response in some series). Multiple injections at 2–4 week intervals. Allergic reactions possible; epinephrine should be available. Available through veterinary practitioners.
Topical Imiquimod (Aldara 5% cream)
Imiquimod is a toll-like receptor agonist that stimulates local immune responses. Applied topically 3 times weekly to occult or verrucous sarcoids for weeks to months. Evidence is modest but positive in some case series; best suited for flat periocular lesions where other treatments carry high risk of ocular damage. Available by veterinary prescription. Requires owner commitment to regular application.
Watch and Wait (Active Monitoring)
For small, stable, non-irritated occult or verrucous sarcoids in locations that are not causing welfare problems, some veterinarians recommend monitoring without treatment, particularly in areas where treatment-induced transformation is a significant risk. This requires regular (at least 3-monthly) reassessment. Not appropriate for rapidly enlarging or irritated lesions.
The Golden Rules of Sarcoid Management
- Get a proper diagnosis first. Not every raised skin lesion is a sarcoid; wrong diagnosis leads to wrong treatment
- Consult a vet with equine dermatology experience. General recommendations fail regularly on sarcoids; referral to an equine dermatologist or oncologist is appropriate for complex cases
- Never traumatize a sarcoid without a treatment plan. No scratching, rubbing with equipment, ill-fitting tack, or biopsy without immediate follow-up treatment
- Match treatment to type and location. There is no universal protocol
- Plan for follow-up. Even “successful” treatments require monitoring for recurrence
- Protect wound sites. Fly control around existing lesions and wounds reduces re-inoculation risk
Prognosis
- Single, stable occult lesion: good prognosis for long-term stability with monitoring
- Verrucous or nodular in accessible locations: good prognosis with appropriate treatment
- Periocular sarcoids: guarded — treatment carries ocular risk; specialist care strongly recommended
- Fibroblastic on lower limbs: guarded — high recurrence risk; may require multiple treatment modalities
- Malevolent/infiltrating: poor for resolution; management aims at slowing progression and maintaining welfare
When to Involve Your Vet Immediately
- Any lesion near the eye — do not delay; periocular sarcoids are the most functionally threatening
- Rapid change in size or character of any skin lesion
- Lesion bleeding, ulcerating, or attracting excessive fly activity
- Multiple new lesions appearing simultaneously
- Any lesion in the groin, axilla, or sheath that is enlarging
This article is for educational purposes only. Sarcoid management should be guided by a veterinarian with experience in equine dermatology. It does not constitute veterinary advice.
For other skin conditions, see our articles on Rain Rot, Sweet Itch, and Hair Loss in Horses. For coat-color genetics and conditions that can be confused with coat-pattern variation, the equine coat genetics resource at Brindle Horses covers the hereditary brindle pattern in depth. Quick equine health reference at horse-info.org.
